AstraZeneca to onshore rare disease portfolio as part of its $50B pledge to the US
AstraZeneca will invest $2 billion to expand its presence in Maryland, its latest move to boost US manufacturing as part of a larger $50 billion pledge, the com...
AstraZeneca will invest $2 billion to expand its presence in Maryland, its latest move to boost US manufacturing as part of a larger $50 billion pledge, the company announced Friday.
The UK-based drugmaker will use ...